$0.29 EPS Expected for National Research Corporation (NRCIA)

April 17, 2018 - By Christine McCrea

National Research Corporation (NASDAQ:NRCIA) LogoInvestors sentiment decreased to 1.75 in 2017 Q4. Its down 0.07, from 1.82 in 2017Q3. It dived, as 5 investors sold National Research Corporation shares while 19 reduced holdings. 15 funds opened positions while 27 raised stakes. 8.18 million shares or 35.51% more from 6.04 million shares in 2017Q3 were reported.
Metropolitan Life New York accumulated 3,511 shares or 0% of the stock. Parallax Volatility Advisers L P has invested 0% in National Research Corporation (NASDAQ:NRCIA). Cap Impact Advsr Lc reported 0.58% stake. Neuberger Berman Grp Inc Lc invested in 44,258 shares. Strs Ohio holds 20,400 shares or 0% of its portfolio. State Street holds 167,870 shares. Fifth Third Commercial Bank accumulated 0% or 35 shares. Hillsdale Invest Management holds 18,534 shares or 0.11% of its portfolio. State Bank Of Montreal Can holds 0% or 441 shares. Morgan Stanley reported 41,777 shares stake. Virtus Inv Advisers stated it has 0.01% in National Research Corporation (NASDAQ:NRCIA). Alliancebernstein Limited Partnership has invested 0% in National Research Corporation (NASDAQ:NRCIA). California-based California Employees Retirement has invested 0% in National Research Corporation (NASDAQ:NRCIA). Glenmede Tru Company Na has invested 0% of its portfolio in National Research Corporation (NASDAQ:NRCIA). Blackrock Inc owns 476,279 shares.

Since January 25, 2018, it had 1 buying transaction, and 9 sales for $58.65 million activity. Shares for $106.10 million were bought by Amandla MK Trust on Thursday, February 15. Shares for $62.54M were sold by Hays Michael D..

Analysts expect National Research Corporation (NASDAQ:NRCIA) to report $0.29 EPS on May, 1.They anticipate $0.03 EPS change or 11.54 % from last quarter’s $0.26 EPS. NRCIA’s profit would be $7.69M giving it 28.49 P/E if the $0.29 EPS is correct. After having $0.10 EPS previously, National Research Corporation’s analysts see 190.00 % EPS growth. The stock increased 1.23% or $0.4 during the last trading session, reaching $33.05. About 10,160 shares traded. National Research Corporation (NASDAQ:NRCIA) has risen 44.75% since April 17, 2017 and is uptrending. It has outperformed by 33.20% the S&P500.

National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. The company has market cap of $876.02 million. The Company’s portfolio of subscription solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. It has a 36.64 P/E ratio. The firm offers Market Insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

National Research Corporation (NASDAQ:NRCIA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.